pCG-TPMV Hd32-IL-13
(Plasmid
#163869)
-
PurposeExpresses TPMV H glycoprotein bearing IL-13 in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 163869 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCG
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTPMV H glycoprotein/IL-13
-
Alt nameTPMV hemagglutinin and IL-13
-
SpeciesH. sapiens (human), Synthetic
-
MutationAmino acids 2 to 33 at N terminus deleted
-
Tag
/ Fusion Protein
- Human IL-13 (C terminal on insert)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCG-TPMV Hd32-IL-13 was a gift from Jakob Reiser (Addgene plasmid # 163869 ; http://n2t.net/addgene:163869 ; RRID:Addgene_163869) -
For your References section:
In vivo targeting of lentiviral vectors pseudotyped with the Tupaia paramyxovirus H glycoprotein bearing a cell-specific ligand. Argaw T, Marino MP, Timmons A, Eldridge L, Takeda K, Li P, Kwilas A, Ou W, Reiser J. Mol Ther Methods Clin Dev. 2021 Apr 24;21:670-680. doi: 10.1016/j.omtm.2021.04.012. eCollection 2021 Jun 11. 10.1016/j.omtm.2021.04.012 PubMed 34141822